Skip to main content
Clinical Trials/NCT06450964
NCT06450964
Enrolling By Invitation
Not Applicable

Establishment of Reproductive Cohort and Prediction Model of Genetic Counseling for Mitochondrial Genetic Diseases

Anhui Medical University1 site in 1 country600 target enrollmentSeptember 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mitochondrial Diseases
Sponsor
Anhui Medical University
Enrollment
600
Locations
1
Primary Endpoint
Symptoms of mitochondrial disease
Status
Enrolling By Invitation
Last Updated
last year

Overview

Brief Summary

The goal of this observational study is to provide a reference for clinicians to conduct genetic counseling and carry out preimplantation genetic testing of mitochondrial patients. The main questions it aims to answer are:

  • The relationship between mitochondrial mutation load and clinical symptom
  • The symptomatic threshold of common mitochondrial DNA mutations
  • The distribution of mitochondrial mutation load in offspring and genetic rule of mitochondrial DNA mutation
  • The minimum number of eggs taken by preimplantation genetic testing in mitochondrial mutation carriers Biological samples such as blood, urine, oral epithelial cells, nails, some granulosa cells, trophoderm cells, embryo culture fluid, embryo biopsy fluid, and embryo trophoblast cells of the participants will be collected and the mutation loads of them will be measured. The clinical symptoms and mutation load of the participants will be followed up once a year.

Detailed Description

A total of 600 carriers of disease-causing mitochondrial DNA mutations will be selected as the research objects. The basic information, reproductive history, clinical and genetic diagnosis, and clinical symptoms of the carriers will be investigated by questionnaire. Biological samples such as blood, urine, oral epithelial cells, nails, some granulosa cells, trophoderm cells, embryo culture fluid, embryo biopsy fluid, and embryo trophoblast cells of the participants will be collected and the mutation loads of them will be measured. Placenta and umbilical cord blood samples of some fetuses will be collected after delivery, and the mitochondrial DNA mutation heterogeneity level will be determined. Multiple Logistic regression, Sewell-Wright equation, Kimura equation, binomial distribution model, and machine learning model will be used to establish a prediction model of the incidence probability of mitochondrial diseases and predict the onset threshold of common mitochondrial DNA mutations after standardizing. The distribution model of mitochondrial mutation load in offspring will be established to predict the maternal genetic risk of mitochondrial DNA mutation. A prediction model for egg retrieval will be established to estimate the minimum number of eggs taken by preimplantation genetic testing in mitochondrial mutation carriers. Finally, an online prediction platform for mitochondrial genetic disease genetic counseling will be established to provide standardized standards for mitochondrial disease genetic counseling and PGT.

Registry
clinicaltrials.gov
Start Date
September 1, 2024
End Date
December 31, 2027
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Anhui Medical University
Responsible Party
Principal Investigator
Principal Investigator

Dongmei Ji

Principal Investigator

Anhui Medical University

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of mitochondrial DNA diseases

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Symptoms of mitochondrial disease

Time Frame: 3 years

The enrolled patients were followed up once a year. Symptoms that the patient has due to mitochondrial DNA mutations are recorded.

Secondary Outcomes

  • level of mitochondrial DNA mutation(3 years)
  • Tissue-specific distribution of mitochondrial DNA mutation levels(When they enrolled)

Study Sites (1)

Loading locations...

Similar Trials